BRCA2 and hyperinsulinemic hypoglycemia, familial, 4: Here, we develop a genome-wide mutational scar-based pan-cancer Classifier of HOmologous Recombination Deficiency (CHORD) that can discriminate BRCA1- and BRCA2-subtypes.